A new, placenta-based cell therapy may be effective at thwarting a common medical complication during pregnancy that can put both mother and child at risk, and in rare cases, cause death.
Researchers have transformed human embryonic stem cells into nerve cells that helped mice regain the ability to learn and remember, a notable feat in stem cell research that could lead to new models for drug screening and discovery.
In what may be the first experiment of its kind, researchers have used microvesicles derived from mesenchymal bone marrow cells to treat brain cancer.
Scientists may be one step closer to using stem cells to treat patients with Parkinson's disease. International Stem Cell Corp. has developed a method to treat the common neurodegenerative disease by replacing lost neurons with new neuronal cells derived from human parthenogenetic stem cells.
Researchers at the University of Wisconsin, Madison, may have found a way to personalize therapies for neurodegenerative diseases like Parkinson's by transforming a monkey's skin cells and implanting them back into its brain.
There's no question that diabetes is on the rise worldwide. The World Health Organization estimates that diabetes will be the seventh leading cause of death in 2030. Up to 25% of this population will get a foot ulcer at some point in their life.
Up until now, the origin of aggressive ovarian cancer has eluded scientists. But researchers at Cornell University have discovered the source of stem cell-like cells that can give rise to ovarian cancer in mice.
Researchers from the Oregon Health & Science University Doernbecher Children's Hospital claim to have developed a method to grow liver stem cells in culture, a breakthrough that could be significant in advancing hepatitis research, transplantation for cirrhosis and other chronic liver conditions, and for conducting drug-metabolism and toxicity studies.
Eleven scientists have been named winners of the Breakthrough Prize in Life Sciences prize. The scientists, whose specialties include genetics, stem cells and cancer, will receive $3 million each to pursue scientific projects.
The first clinical study to put induced pluripotent stem (iPS) cells into humans is soon to get under way in Japan, where an institutional review board at the Institute for Biomedical Research and Innovation gave conditional approval.